180 search results for: type 2 inflammation

In this ADVENT symposium at the 2024 EADV meeting, Dr. Donna Culton focuses on the challenges of diagnosis and the unmet needs for patients with BP.

Dr. Donna Culton focuses on the challenges of diagnosis and the unmet needs for patients with BP

Join Dr. Teri Greiling as she discusses the heterogeneous clinical presentations seen in bullous pemphigoid (BP). She also shares diagnostic challenges, including the unclear epidemiology and the extensive differential diagnoses faced by patients with BP.

Learn about the clinical presentation of CSU and the burden many CSU patients face by following one patient’s journey from symptom presentation to CSU diagnosis in this 5-minute video.

Professor Joost Meijer discusses the complex etiology and diagnosis of BP

Join Dr. Victoria Werth as she shares the unmet needs and management challenges experienced by patients with bullous pemphigoid (BP), including physical, mental, socioeconomic, and treatment-related burdens. She expands on the comorbidities and increased mortality rates these patients may face.

Professors Netchiporouk and Hawkes discuss the clinical features and pathophysiology of CSU, at EADV 2025.

Experience this engaging presentation by Professors Martin Metz, Elena Netchiporouk, and Jason Hawkes to explore emerging therapies for chronic spontaneous urticaria.

Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.

Join Lisa Swanson, MD, and Gina Mangin, MPAS, PA-C as they discuss the evaluation of the cytokine hierarchy in AD and the contributions of IL-4, IL-13, and IL-31 to itch.